AHPA

Organogenesis Holdings Inc.

A regenerative medicine company that grows living skin and tissue products to help wounds heal. Its best-known product, Apligraf, is a living skin substitute used to treat diabetic foot ulcers and venous leg ulcers, while its PuraPly and Affinity lines provide antimicrobial and amniotic membrane dressings for surgeons and wound-care clinics. Founded in 1985 in Massachusetts, the company's name reflects its founding mission of growing organs and tissues in the lab rather than just making bandages.

Class A ordinary shares — Merged with Organogenesis Inc. in December 2018, became Organogenesis Holdings Inc. (ORGO)

No filing summaries or text available for this security.